Andrew Wang

15.6k total citations · 1 hit paper
241 papers, 7.4k citations indexed

About

Andrew Wang is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Andrew Wang has authored 241 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Cardiology and Cardiovascular Medicine, 66 papers in Epidemiology and 56 papers in Surgery. Recurrent topics in Andrew Wang's work include Cardiac Valve Diseases and Treatments (66 papers), Infective Endocarditis Diagnosis and Management (48 papers) and Cardiomyopathy and Myosin Studies (45 papers). Andrew Wang is often cited by papers focused on Cardiac Valve Diseases and Treatments (66 papers), Infective Endocarditis Diagnosis and Management (48 papers) and Cardiomyopathy and Myosin Studies (45 papers). Andrew Wang collaborates with scholars based in United States, France and Spain. Andrew Wang's co-authors include Vivian H. Chu, Thomas M. Bashore, Jeffrey G. Gaca, Christopher H. Cabell, Vance G. Fowler, C.G. Sodini, G. Ralph Corey, Patrick Murray, James A. Tumlin and Ted Feldman and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Andrew Wang

224 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management Considerations in Infective Endocarditis

2018 231 citations Andrew Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Wang United States	44	3.7k	3.0k	2.0k	1.0k	901	241	7.4k
Kunihiro Nishimura Japan	44	2.8k 0.8×	1.4k 0.5×	1.7k 0.9×	356 0.4×	682 0.8×	444	9.4k
Shelley Hurwitz United States	51	1.1k 0.3×	942 0.3×	1.4k 0.7×	712 0.7×	614 0.7×	160	7.8k
Roch Giorgi France	40	1.6k 0.4×	1.5k 0.5×	1.3k 0.6×	488 0.5×	576 0.6×	199	5.7k
J. Alberto San Román Spain	40	2.9k 0.8×	2.7k 0.9×	2.0k 1.0×	1.1k 1.1×	959 1.1×	367	5.8k
Éric Rosenthal United Kingdom	48	2.1k 0.6×	4.1k 1.3×	1.3k 0.7×	940 0.9×	1.0k 1.1×	287	8.7k
Jennifer E. Ho United States	54	5.2k 1.4×	782 0.3×	1.4k 0.7×	295 0.3×	299 0.3×	194	9.6k
Norman Waugh United Kingdom	48	789 0.2×	1.7k 0.6×	2.2k 1.1×	381 0.4×	549 0.6×	166	8.6k
Bernard Prendergast United Kingdom	46	6.5k 1.8×	5.1k 1.7×	2.5k 1.2×	1.9k 1.8×	1.3k 1.4×	224	9.7k
Hilal Maradit Kremers United States	58	2.2k 0.6×	1.2k 0.4×	6.8k 3.4×	227 0.2×	734 0.8×	210	20.4k
Petra Reinke Germany	64	525 0.1×	5.5k 1.8×	2.7k 1.4×	1.4k 1.3×	904 1.0×	367	15.5k

Countries citing papers authored by Andrew Wang

Since Specialization

Citations

This map shows the geographic impact of Andrew Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Wang more than expected).

Fields of papers citing papers by Andrew Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Wang. The network helps show where Andrew Wang may publish in the future.

Co-authorship network of co-authors of Andrew Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Wang. A scholar is included among the top collaborators of Andrew Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Wang. Andrew Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kwak, Soongu, Jihoon Kim, Chan Soon Park, et al.. (2025). Prognostic Implication of Left Ventricular Global Longitudinal Strain in Patients With Hypertrophic Cardiomyopathy and Coexisting Hypertension. Korean Circulation Journal. 55(7). 584–584. 1 indexed citations

Zou, Yushi, Abdulrahman Aldossary, Jie Bai, et al.. (2025). El Agente: An autonomous agent for quantum chemistry. Matter. 8(7). 102263–102263. 9 indexed citations

Judge, Carolyn Q., et al.. (2024). Laparoscopic-Assisted Transvaginal Cholecystectomy – the US Military Experience With Long-Term Follow Up. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 28(1). e2023.00059–e2023.00059. 2 indexed citations

Balki, Mrinalini, et al.. (2024). Differential sensory block during labour epidural analgesia: a prospective observational study to investigate the relationship of lower and upper sensory block levels to cold, pinprick, and light touch. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 71(6). 802–807. 3 indexed citations

Desai, Milind Y., Kathy Wolski, Anjali Owens, et al.. (2024). Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM. Circulation. 151(19). 1378–1390. 14 indexed citations

Rymer, Jennifer A., Jie‐Lena Sun, Karen Chiswell, et al.. (2023). Variation in resource utilization and mortality among patients with varying MR type and severity. American Heart Journal. 260. 44–57. 1 indexed citations

Drescher, Caitlin, Michelle D. Kelsey, Albert Y. Sun, et al.. (2022). Imaging Considerations and Clinical Implications of Mitral Annular Disjunction. Circulation Cardiovascular Imaging. 15(9). e014243–e014243. 16 indexed citations

Desai, Milind Y., Anjali Owens, Jeffrey B. Geske, et al.. (2022). Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Circulation. 147(11). 850–863. 53 indexed citations

Wang, Andrew & Emil Loldrup Fosbøl. (2021). Current recommendations and uncertainties for surgical treatment of infective endocarditis: a comparison of American and European cardiovascular guidelines. European Heart Journal. 43(17). 1617–1625. 31 indexed citations

10.

Wang, Andrew, et al.. (2021). Demonstration of tethered hovering flight of HTTP-3AT hybrid rocket. Acta Astronautica. 191. 279–292. 24 indexed citations

11.

Heitner, Stephen B., Daniel Jacoby, Steven J. Lester, et al.. (2019). Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy. Annals of Internal Medicine. 5 indexed citations

12.

Heitner, Stephen B., Andrew Wang, Sheila M. Hegde, et al.. (2019). Abstract 13962: Precision Pharmacological Treatment for Obstructive Hypertrophic Cardiomyopathy With Mavacamten: One-Year Results From PIONEER-OLE. Circulation. 4 indexed citations

13.

Wang, Hong, Yanping Yang, Andrew Wang, et al.. (2018). Clinical study on hematoma puncture and catheter drainage in treatment of intracerebral hemorrhage under CT real-time guide. SHILAP Revista de lepidopterología. 1 indexed citations

14.

Olivotto, Iacopo, Carolyn Y. Ho, Daniel Jacoby, et al.. (2018). Abstract 16466: EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy. Circulation. 2 indexed citations

15.

Østergaard, Lauge, Nana Valeur, Andrew Wang, et al.. (2018). Incidence of infective endocarditis in patients considered at moderate risk. European Heart Journal. 40(17). 1355–1361. 31 indexed citations

16.

Samad, Zainab, Linda K. Shaw, Matthew Phelan, et al.. (2015). Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. European Heart Journal. 36(40). 2733–2741. 43 indexed citations

17.

Hart, Stephen A., et al.. (2010). Pulmonary hypertension and elevated transpulmonary gradient in patients with mitral stenosis.. PubMed. 19(6). 708–15. 39 indexed citations

18.

Bashore, Thomas M., et al.. (2007). Pure annular dilation as a cause of mitral regurgitation: a clinically distinct entity of female heart disease.. PubMed. 18(3). 284–47. 15 indexed citations

19.

Wang, Andrew, Michael R. Darby, & Lynne G. Zucker. (2003). Universities, Joint Ventures, and Success in the Advanced Technology Program. SSRN Electronic Journal. 2 indexed citations

20.

Moulias, R, et al.. (1978). [Cardiac diseases and anti-heart cellular autoimmunity].. PubMed. 17(2). 175–81.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact